6
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Depletion of high-affinity corticosteroid-binding globulin corresponds to illness severity in sepsis and septic shock; clinical implications.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Corticosteroid-binding globulin (CBG) is cleaved by neutrophil elastase converting the high-affinity (haCBG) conformation of CBG to a low-affinity (laCBG) conformation with a ninefold reduced cortisol-binding affinity. These in vitro data suggest that cortisol release by CBG cleavage results in the targeted delivery of cortisol to areas of inflammation. Our objective was to determine whether CBG cleavage alters circulating levels of haCBG and laCBG in vivo in proportion to sepsis severity.

          Related collections

          Author and article information

          Journal
          Clin. Endocrinol. (Oxf)
          Clinical endocrinology
          1365-2265
          0300-0664
          Jun 2015
          : 82
          : 6
          Affiliations
          [1 ] Endocrine and Metabolic Unit, Royal Adelaide Hospital, Adelaide, SA, Australia.
          [2 ] School of Medicine, University of Adelaide, Adelaide, SA, Australia.
          [3 ] Chemical Pathology Directorate, SA Pathology, Adelaide, SA, Australia.
          [4 ] Intensive Care Unit, Royal Adelaide Hospital, Adelaide, SA, Australia.
          [5 ] Experimental Therapeutics Laboratory, Hanson Institute and Sansom Institute, University of South Australia, Adelaide, SA, Australia.
          [6 ] Robinson Research Institute and School of Paediatrics and Reproductive Health, University of Adelaide, Adelaide, SA, Australia.
          [7 ] Steroid and Immunobiochemistry Laboratory, Canterbury Health Laboratories, Christchurch, New Zealand.
          Article
          10.1111/cen.12680
          25409953
          3ef3b6a3-a895-4689-adf6-cc7f8db1543b
          © 2015 John Wiley & Sons Ltd.
          History

          Comments

          Comment on this article